La innovación en movimiento
| Date - Category | Illustration | Title | Excerpt |
|---|---|---|---|
|
|
Spineart proudly announces the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCARLET® AC-Ti secured anterior cervical cage. The SCARLET® AC-Ti builds on a decade of...
|
|
|
|
SpinEM Robotics, a leading deep tech startup specializing in cutting-edge navigation solutions for robotic spinal surgery, is thrilled to announce a significant milestone in its innovation journey. The company has...
|
|
|
|
Spineart has successfully raised a CHF20 million convertible financing. The funding comes on the heels of the completion of enrollment in the two BAGUERA® C IDE studies, underlining Spineart’s commitment...
|
|
|
|
Spineart SA today announced it has completed enrollment in its U.S. IDE trial studying the BAGUERA®C Cervical Disc Prosthesis in patients with cervical disc disease at two contiguous levels between...
|
|
|
SPINEART completes enrollment in the BAGUERA® C IDE trial for single-level cervical disc replacement
|
Spineart SA, manufacturer of the BAGUERA®C Cervical Disc Prosthesis, is delighted to announce completion of enrollment in its U.S. IDE trial studying the BAGUERA®C Cervical Disc Prosthesis in patients with...
|
|
|
|
On September 1st, 2023, Spineart SA entered into a distribution agreement with Solco Biomedical of Republic of Korea. Since January 1st, 2024, Solco is the sole distributor of BAGUERA® C,...
|
|
|
|
We are building a new factory and broke ground on October 26th, 2023. Built on a 7,000 sqm (70,000 sqft) greenfield development lot, the new Spineart factory is our third...
|
|
|
|
For the first time in its history, Spineart has reached and surpassed €100m of trailing 12-month revenue. As the success and expansion of the Ti-LIFE ranges continues, we are rolling...
|
|
|
|
After the 5-Year clinical results published in 2018, we are proud to announce that the European Spine Journal has just published the 10-Year results. 81 patients continued their follow up to 10-years and...
|
|
|
|
On April 1st, 2023, Spineart SA has entered into an exclusive distribution agreement with Sanyou Medical to sell Spineart technologies in China. Both companies will cooperate particularly in the field...
|
|
|
|
Heidi News (Swiss media) is dedicating an article to Spineart in a series on the Genevan industrial power! Read the article (French only)
|
|
|
|
Geneva, a business in action: Spineart and its innovative work benefit spinal surgery technology. Read the article – 1st half-year 2023
|
